-
Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile
09 Dec 2025 12:00 GMT
… in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients … patients with relapsed or refractory Acute Myeloid Leukemia (R/R AML). Data …
-
Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia
09 Dec 2025 12:00 GMT
… /Refractory (R/R) Acute Myeloid Leukemia (AML) based on preliminary clinical …
-
<![CDATA[In CLL, New Therapies Offer Potential for Personalized Approaches]]>
13 Dec 2025 20:20 GMT
… of developing myelodysplastic syndrome or acute myeloid leukemia.1
For those and other …
-
Capital Region rallies for stem cell donor event to aid local leukemia patient
13 Dec 2025 18:34 GMT
… as she's battling Acute Myeloid Leukemia.
On Sunday, Katie’s family …
-
<![CDATA[FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC]]>
13 Dec 2025 03:49 GMT
… warnings for myelodysplastic syndrome/acute myeloid leukemia, myelosuppression, hypokalemia, fluid retention, and …
-
HGTV Tragedies: The Saddest and Most Shocking Deaths Through the Years
13 Dec 2025 02:53 GMT
… died in June 2025 of acute myeloid leukemia. He was 55.
Ruch had …
-
U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*
13 Dec 2025 01:56 GMT
… Syndrome/Acute Myeloid Leukemia
AKEEGA® may cause myelodysplastic syndrome/acute myeloid leukemia (MDS…
-
<![CDATA[FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer]]>
13 Dec 2025 01:28 GMT
… potential for myelodysplastic syndrome/acute myeloid leukemia. Grade 3/4 adverse …
-
<![CDATA[ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care]]>
12 Dec 2025 23:50 GMT
… intensive chemotherapy among patients with acute myeloid leukemia (AML) across 10 ECOG … Plus Venetoclax Improves EFS in Acute Myeloid Leukemia
Combining venetoclax (Venclexta) with … newly diagnosed fit adults with acute myeloid leukemia. Blood. 2025;146(suppl …
-
<![CDATA[FDA Approves Niraparib Regimen in BRCA2+ Metastatic CSPC]]>
12 Dec 2025 23:50 GMT
… warnings for myelodysplastic syndrome or acute myeloid leukemia, myelosuppression, fluid retention, hepatoxicity, hypogylcemia …